Literature DB >> 2510158

Agkistrodon piscivorus piscivorus platelet aggregation inhibitor: a potent inhibitor of platelet activation.

B H Chao1, J A Jakubowski, B Savage, E P Chow, U M Marzec, L A Harker, J M Maraganore.   

Abstract

Applaggin (Agkistrodon piscivorus piscivorus platelet aggregation inhibitor) is a potent inhibitor of platelet activation. The protein is isolated from the venom of the North American water moccasin snake in three steps, including gel filtration, cation exchange, and reverse-phase HPLC procedures. The purified protein migrates as a 17,700-Da polypeptide by SDS/PAGE under nonreducing conditions and as a 9800-Da peptide in the presence of thiol. The behavior of applaggin on SDS/PAGE would indicate that the protein is a disulfide-linked dimer. Applaggin has been completely sequenced by Edman degradation and consists of 71 amino acids. The sequence is rich in cysteine and contains Arg-Gly-Asp at residues 50-52. Applaggin blocks platelet aggregation induced by ADP, collagen, thrombin, or arachidonic acid with IC50 values ranging from 12 to 128 nM (0.2-2.3 micrograms/ml) depending on the agonist and its concentration. This inhibition is found to correlate with inhibition of thromboxane A2 generation and of dense granule release of serotonin. Inhibition by applaggin of serotonin release induced by ADP, gamma-thrombin, and collagen was monitored in plasma under stirred conditions with [3H]serotonin-loaded platelets, and IC50 values for inhibition are found to range from less than 10 to 145 nM. At saturating concentrations, 125I-labeled applaggin (125I-applaggin) binds to 28,500 sites per unstimulated, washed platelet with a Kd of 1.22 x 10(-7) M. Binding of 125I-applaggin to platelets is inhibited by the synthetic undecapeptide Arg8-Gly-Asp-Val at 200 microM.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2510158      PMCID: PMC298212          DOI: 10.1073/pnas.86.20.8050

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation.

Authors:  S J Shattil; J A Hoxie; M Cunningham; L F Brass
Journal:  J Biol Chem       Date:  1985-09-15       Impact factor: 5.157

2.  Effects of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the baboon.

Authors:  S R Hanson; F I Pareti; Z M Ruggeri; U M Marzec; T J Kunicki; R R Montgomery; T S Zimmerman; L A Harker
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

Review 3.  Cytoadhesins, integrins, and platelets.

Authors:  M H Ginsberg; J C Loftus; E F Plow
Journal:  Thromb Haemost       Date:  1988-02-25       Impact factor: 5.249

4.  Inhibition of platelet function with synthetic peptides designed to be high-affinity antagonists of fibrinogen binding to platelets.

Authors:  Z M Ruggeri; R A Houghten; S R Russell; T S Zimmerman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

5.  Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex.

Authors:  T F Huang; J C Holt; H Lukasiewicz; S Niewiarowski
Journal:  J Biol Chem       Date:  1987-11-25       Impact factor: 5.157

6.  The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets.

Authors:  E F Plow; M D Pierschbacher; E Ruoslahti; G A Marguerie; M H Ginsberg
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

7.  Inhibition of human platelet function in vivo with a monoclonal antibody. With observations on the newly dead as experimental subjects.

Authors:  B S Coller; L E Scudder; H J Berger; J D Iuliucci
Journal:  Ann Intern Med       Date:  1988-10-15       Impact factor: 25.391

8.  The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets.

Authors:  T K Gartner; J S Bennett
Journal:  J Biol Chem       Date:  1985-10-05       Impact factor: 5.157

9.  Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs.

Authors:  T Yasuda; H K Gold; J T Fallon; R C Leinbach; J L Guerrero; L E Scudder; M Kanke; D Shealy; M J Ross; D Collen; B S Coller
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

10.  Antithrombotic effect of a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptor in an experimental animal model.

Authors:  B S Coller; J D Folts; L E Scudder; S R Smith
Journal:  Blood       Date:  1986-09       Impact factor: 22.113

View more
  8 in total

1.  Antithrombotic effects of synthetic peptides targeting various functional domains of thrombin.

Authors:  A B Kelly; J M Maraganore; P Bourdon; S R Hanson; L A Harker
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

2.  Amino acid sequence and molecular modelling of glycoprotein IIb-IIIa and fibronectin receptor iso-antagonists from Trimeresurus elegans venom.

Authors:  A Scaloni; E Di Martino; N Miraglia; A Pelagalli; R Della Morte; N Staiano; P Pucci
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

3.  The integrin alpha IIb beta 3 contains distinct and interacting binding sites for snake-venom RGD (Arg-Gly-Asp) proteins. Evidence that the receptor-binding characteristics of snake-venom RGD proteins are related to the amino acid environment flanking the sequence RGD.

Authors:  S Rahman; X Lu; V V Kakkar; K S Authi
Journal:  Biochem J       Date:  1995-11-15       Impact factor: 3.857

Review 4.  Novel antithrombotic drugs in development.

Authors:  M Verstraete; P Zoldhelyi
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

5.  Interaction of disintegrins with the alpha IIb beta 3 receptor on resting and activated human platelets.

Authors:  M A McLane; M A Kowalska; L Silver; S J Shattil; S Niewiarowski
Journal:  Biochem J       Date:  1994-07-15       Impact factor: 3.857

6.  Triflavin, an Arg-Gly-Asp-containing antiplatelet peptide inhibits cell-substratum adhesion and melanoma cell-induced lung colonization.

Authors:  J R Sheu; C H Lin; J L Chung; C M Teng; T F Huang
Journal:  Jpn J Cancer Res       Date:  1992-08

7.  Triflavin, an Arg-Gly-Asp-containing peptide, inhibits tumor cell-induced platelet aggregation.

Authors:  J R Sheu; C H Lin; H C Peng; C M Teng; T F Huang
Journal:  Jpn J Cancer Res       Date:  1993-10

Review 8.  Exogenous Integrin αIIbβ3 Inhibitors Revisited: Past, Present and Future Applications.

Authors:  Danique L van den Kerkhof; Paola E J van der Meijden; Tilman M Hackeng; Ingrid Dijkgraaf
Journal:  Int J Mol Sci       Date:  2021-03-25       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.